Pharmetics recalls OTC productsPharmetics Inc. is voluntarily recalling selected lots of six OTC drugs from the Canadian market. Canada should follow U.S. in using diabetes testHemoglobin A1c test catches dysglycemia earlier than glucose test The new theory of (fee) relativity In Ontario, GPs are more comfortable. Other sections now have concerns but (mostly) accept the new process CPhA, Aglukkaq hold first meeting Sustained-release lithium back on the market AA Pharma introducing Lithmax (lithium carbonate 300 mg sustained-release tablets). Alberta patients rate pharmacists' services highly MDs play trigger role in new health loyalty rewards strategy Imagine your patients receiving rewards for following your advice Top Rx Drugs of 2010 Generics reign supreme in annual ranking. Baxter introduces triple-chamber bag for parenteral nutrition Updated Canadian ADHD guidelines Guidelines designed to aid in the diagnosis and treatment of ADHD across the patient’s life span. Adverse Reactions: Clopidogrel–PPI interaction revisited Some proton pump inhibitors may be associated with a decrease in the antiplatelet effect of clopidogrel and an increased risk of cardiac events. Adverse Reactions: Sibutramine - increased cardiovascular risks Sibutramine voluntarily withdrawn from Canadian and American markets in October 2010. First Previous 907 908 909 910 911 Next Last
